The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Immunoglobulins
".
FunFam 370: CMRF35-like molecule 1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 16 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
14 |
A0A0K2S4Q6 (/IPI)
O95944 (/IPI)
Q3LRV9 (/IPI)
Q3U497 (/IPI)
Q6SJQ0 (/IPI)
Q6SJQ5 (/IPI)
Q6SJQ7 (/IPI)
Q6SJQ7 (/IPI)
Q6UXG3 (/IPI)
Q6UXZ3 (/IPI)
(4 more) |
Virus receptor activity GO:0001618
Combining with a virus component and mediating entry of the virus into the cell.
|
3 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) Q8VCH2 (/IMP) |
Phosphatidylserine binding GO:0001786
Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
3 | Q6SJQ7 (/IDA) Q6SJQ7 (/IDA) Q9UGN4 (/IDA) |
Ceramide binding GO:0097001
Interacting selectively and non-covalently with any ceramide, a class of lipids that is composed of sphingosine linked to a fatty acid. Ceramides are a major component of cell membranes.
|
3 | Q6SJQ7 (/IDA) Q6SJQ7 (/IDA) Q8TDQ1 (/IDA) |
Phosphatidylserine binding GO:0001786
Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
2 | O95944 (/TAS) Q08708 (/TAS) |
Interleukin-4 receptor binding GO:0005136
Interacting selectively and non-covalently with the interleukin-4 receptor.
|
2 | Q6SJQ7 (/IDA) Q6SJQ7 (/IDA) |
Interleukin-4 receptor binding GO:0005136
Interacting selectively and non-covalently with the interleukin-4 receptor.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Ceramide binding GO:0097001
Interacting selectively and non-covalently with any ceramide, a class of lipids that is composed of sphingosine linked to a fatty acid. Ceramides are a major component of cell membranes.
|
2 | Q6SJQ7 (/ISO) Q6SJQ7 (/ISO) |
Phosphatidylserine binding GO:0001786
Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
1 | Q6SJQ0 (/ISO) |
IgM binding GO:0001791
Interacting selectively and non-covalently with an immunoglobulin of the IgM isotype.
|
1 | Q1ERP8 (/IDA) |
Phosphatidylethanolamine binding GO:0008429
Interacting selectively and non-covalently with phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
|
1 | Q9UGN4 (/IDA) |
Phosphatidylethanolamine binding GO:0008429
Interacting selectively and non-covalently with phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
|
1 | Q6SJQ0 (/ISO) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
1 | Q9UGN4 (/IDA) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
1 | Q6SJQ0 (/ISO) |
Ceramide binding GO:0097001
Interacting selectively and non-covalently with any ceramide, a class of lipids that is composed of sphingosine linked to a fatty acid. Ceramides are a major component of cell membranes.
|
1 | Q566E6 (/ISS) |
There are 74 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
9 | A8K4G0 (/TAS) O95944 (/TAS) Q08708 (/TAS) Q496F6 (/TAS) Q6UXG3 (/TAS) Q6UXN2 (/TAS) Q6UXZ3 (/TAS) Q8TDQ1 (/TAS) Q9UGN4 (/TAS) |
Negative regulation of MyD88-dependent toll-like receptor signaling pathway GO:0034125
Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.
|
3 | Q6SJQ0 (/ISO) Q6SJQ7 (/ISO) Q6SJQ7 (/ISO) |
Negative regulation of MyD88-dependent toll-like receptor signaling pathway GO:0034125
Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.
|
3 | Q566E6 (/ISS) Q6SJQ7 (/ISS) Q6SJQ7 (/ISS) |
TRIF-dependent toll-like receptor signaling pathway GO:0035666
Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
|
3 | Q566E6 (/ISS) Q6SJQ7 (/ISS) Q6SJQ7 (/ISS) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
3 | A8K4G0 (/TAS) O95944 (/TAS) Q496F6 (/TAS) |
Cellular defense response GO:0006968
A defense response that is mediated by cells.
|
2 | O95944 (/TAS) Q08708 (/TAS) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | Q6SJQ7 (/IDA) Q6SJQ7 (/IDA) |
Negative regulation of mast cell activation GO:0033004
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
|
2 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) |
Negative regulation of mast cell activation GO:0033004
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
|
2 | Q6SJQ7 (/ISO) Q6SJQ7 (/ISO) |
Negative regulation of MyD88-dependent toll-like receptor signaling pathway GO:0034125
Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.
|
2 | Q8TDQ1 (/IMP) Q9UGN4 (/IMP) |
Positive regulation of toll-like receptor 7 signaling pathway GO:0034157
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 7 signaling pathway.
|
2 | Q3LRV9 (/IMP) Q6UXN2 (/IMP) |
Positive regulation of toll-like receptor 9 signaling pathway GO:0034165
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.
|
2 | Q3LRV9 (/IMP) Q6SJQ5 (/IMP) |
TRIF-dependent toll-like receptor signaling pathway GO:0035666
Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
|
2 | Q6SJQ7 (/ISO) Q6SJQ7 (/ISO) |
Interleukin-13-mediated signaling pathway GO:0035772
A series of molecular signals initiated by the binding of interleukin-13 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) |
Interleukin-13-mediated signaling pathway GO:0035772
A series of molecular signals initiated by the binding of interleukin-13 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Negative regulation of mast cell degranulation GO:0043305
Any process that stops, prevents, or reduces the rate of mast cell degranulation.
|
2 | Q6SJQ0 (/IDA) Q9UGN4 (/IDA) |
Positive regulation of interleukin-4-mediated signaling pathway GO:1902216
Any process that activates or increases the frequency, rate or extent of interleukin-4-mediated signaling pathway.
|
2 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) |
Positive regulation of interleukin-4-mediated signaling pathway GO:1902216
Any process that activates or increases the frequency, rate or extent of interleukin-4-mediated signaling pathway.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Negative regulation of apoptotic cell clearance GO:2000426
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
|
2 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) |
Negative regulation of apoptotic cell clearance GO:2000426
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Positive regulation of apoptotic cell clearance GO:2000427
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
|
2 | Q6SJQ7 (/IDA) Q6SJQ7 (/IDA) |
Positive regulation of apoptotic cell clearance GO:2000427
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
|
2 | Q6SJQ7 (/IMP) Q6SJQ7 (/IMP) |
Positive regulation of apoptotic cell clearance GO:2000427
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
|
2 | Q566E6 (/ISS) Q8TDQ1 (/ISS) |
Cytokine production GO:0001816
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | A0A0K2S4Q6 (/IDA) |
Positive regulation of defense response to virus by host GO:0002230
Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication.
|
1 | Q3LRV9 (/IMP) |
Immunoglobulin transcytosis in epithelial cells GO:0002414
The process of transporting immunoglobulin, via transcytosis, from one side of an epithelial cell to the other.
|
1 | Q1ERP8 (/IDA) |
Neutrophil mediated immunity GO:0002446
Any process involved in the carrying out of an immune response by a neutrophil.
|
1 | Q3U497 (/IMP) |
T cell antigen processing and presentation GO:0002457
The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
|
1 | Q3LRV9 (/IMP) |
Serotonin secretion by mast cell GO:0002552
The regulated release of serotonin by a mast cell or group of mast cells.
|
1 | Q6SJQ0 (/IDA) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
1 | Q6SJQ0 (/IDA) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
1 | Q3LRV9 (/IDA) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | O95944 (/TAS) |
Protein localization GO:0008104
Any process in which a protein is transported to, or maintained in, a specific location.
|
1 | Q3LRV9 (/IMP) |
Negative regulation of serotonin secretion GO:0014063
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.
|
1 | Q6SJQ0 (/IDA) |
Neutrophil chemotaxis GO:0030593
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
|
1 | A0A0K2S4Q6 (/IDA) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
1 | Q9UGN4 (/IMP) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
1 | Q6SJQ0 (/ISO) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q6SJQ5 (/IDA) |
Positive regulation of phosphoprotein phosphatase activity GO:0032516
Any process that activates or increases the activity of a phosphoprotein phosphatase.
|
1 | Q9UGN4 (/IDA) |
Positive regulation of phosphoprotein phosphatase activity GO:0032516
Any process that activates or increases the activity of a phosphoprotein phosphatase.
|
1 | Q6SJQ0 (/ISO) |
Regulation of interleukin-6 production GO:0032675
Any process that modulates the frequency, rate, or extent of interleukin-6 production.
|
1 | Q8VCH2 (/IDA) |
Regulation of tumor necrosis factor production GO:0032680
Any process that modulates the frequency, rate, or extent of tumor necrosis factor production.
|
1 | Q8VCH2 (/IDA) |
Negative regulation of mast cell activation GO:0033004
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
|
1 | Q8TDQ1 (/IDA) |
Negative regulation of mast cell activation GO:0033004
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
|
1 | Q566E6 (/ISS) |
Positive regulation of mast cell activation GO:0033005
Any process that activates or increases the frequency, rate, or extent of mast cell activation.
|
1 | Q3U497 (/IDA) |
Negative regulation of mast cell activation involved in immune response GO:0033007
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of mast cell activation involved in immune response GO:0033007
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
|
1 | Q6SJQ0 (/ISO) |
Positive regulation of toll-like receptor 9 signaling pathway GO:0034165
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.
|
1 | Q6SJQ5 (/IDA) |
Positive regulation of toll-like receptor 13 signaling pathway GO:0034181
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 13 signaling pathway.
|
1 | Q3LRV9 (/IMP) |
TRIF-dependent toll-like receptor signaling pathway GO:0035666
Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
|
1 | Q8TDQ1 (/IMP) |
Negative regulation of mast cell degranulation GO:0043305
Any process that stops, prevents, or reduces the rate of mast cell degranulation.
|
1 | Q6SJQ0 (/ISO) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
1 | Q9UGN4 (/TAS) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of fibroblast proliferation GO:0048147
Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of fibroblast proliferation GO:0048147
Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | Q6SJQ0 (/ISO) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
1 | Q7TSN2 (/IDA) |
Regulation of T cell receptor signaling pathway GO:0050856
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | Q9UGN4 (/IDA) |
Regulation of T cell receptor signaling pathway GO:0050856
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of B cell receptor signaling pathway GO:0050859
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of B cell receptor signaling pathway GO:0050859
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of NK T cell activation GO:0051134
Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer T cell activation.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of NK T cell activation GO:0051134
Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer T cell activation.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of phagocytosis, engulfment GO:0060101
Any process that stops, prevents, or reduces the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
|
1 | Q9UGN4 (/IMP) |
Negative regulation of phagocytosis, engulfment GO:0060101
Any process that stops, prevents, or reduces the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
|
1 | Q6SJQ0 (/ISO) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | Q3U497 (/IMP) |
Negative regulation of neutrophil activation GO:1902564
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil activation.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of neutrophil activation GO:1902564
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil activation.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of eosinophil activation GO:1902567
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil activation.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of eosinophil activation GO:1902567
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil activation.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of activation of Janus kinase activity GO:1902569
Any process that stops, prevents or reduces the frequency, rate or extent of activation of JAK (Janus Activated Kinase) kinase activity.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of activation of Janus kinase activity GO:1902569
Any process that stops, prevents or reduces the frequency, rate or extent of activation of JAK (Janus Activated Kinase) kinase activity.
|
1 | Q6SJQ0 (/ISO) |
Negative regulation of eosinophil migration GO:2000417
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil migration.
|
1 | Q9UGN4 (/IDA) |
Negative regulation of eosinophil migration GO:2000417
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil migration.
|
1 | Q6SJQ0 (/ISO) |
There are 14 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
9 | A8K4G0 (/TAS) O95944 (/TAS) Q08708 (/TAS) Q496F6 (/TAS) Q6UXG3 (/TAS) Q6UXN2 (/TAS) Q6UXZ3 (/TAS) Q8TDQ1 (/TAS) Q9UGN4 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | Q6SJQ0 (/IDA) Q7TSN2 (/IDA) Q8VCH2 (/IDA) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | O95944 (/TAS) Q08708 (/TAS) |
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
|
1 | Q6SJQ5 (/IDA) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
1 | Q6SJQ5 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
1 | Q3LRV9 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | Q7TSN2 (/ISS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q9UGN4 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q6SJQ0 (/ISO) |
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
|
1 | Q1ERP8 (/IDA) |
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
|
1 | Q1ERP8 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | Q9UGN4 (/HDA) |
Tertiary granule membrane GO:0070821
The lipid bilayer surrounding a tertiary granule.
|
1 | Q9UGN4 (/TAS) |
Ficolin-1-rich granule membrane GO:0101003
The lipid bilayer surrounding a ficolin-1-rich granule.
|
1 | Q9UGN4 (/TAS) |